Main Article Content

Abstract

ABSTRACT
Background. Despite the availability of vaccine, measles remains a great challenge public health across the world. This study assessed the magnitude of measles outbreak and identify the associated factors of confirmed case health outcome in Mongolia. Methods. This study is a cross sectional survey using 2015-2016 data collected by the National Center for Communicable Diseases and the Ministry of Health in Mongolia. The study population was 3,787 confirmed cases of measles. Results. Out of 3787 subjects, 62.6% of subjects were aged under 6 years old, 50.6% were males, 80.4 % of subjects came from Ulaanbaatar (the capital city of Mongolia) and 69.3% were unemployed. In terms of clinical characteristics, almost all the subjects (98 % and above) experienced fever and rash; 62.5% experienced cough and around one-quarter had coryza and red eyes. Subjects from other cities or rural areas (OR=1.32, 95% CI: 1.12-1.57), unemployed (OR=1.44, 95%CI: 1.14-181) who had fever OR=2.22; 95% CI: 1.25-3.95) had rash (OR=2.16; 95% CI 1.14-4.89), had cough (OR=1.63; 95% CI: 1.42-1.87), had coryza (OR=4.46; 95%CI: 3.79-5.26), had red eyes (OR=2.2195% CI: 1.91-2.56) and with measles PCR positive (OR=2.28, 95% CI: 1.98-2.61) were more likely of being under negative health outcome compared to the reference groups. Conclusion. Higher prevalence of measles was observed in children aged under 6 years and adults aged 18 years and above. The risk of measles was higher among the cases with clinical symptoms. More intervention programs, including children and adult’s vaccination should be done to attenuate measles illness and reduce transmission.


RÉSUMÉ
Introduction. Malgré la disponibilité du vaccin, la rougeole reste un grand défi de santé publique dans le monde. Cette étude a évalué l'ampleur de l'épidémie de rougeole et identifié les facteurs associés à l'évolution de la santé des cas confirmés en Mongolie. Méthodes. Cette étude est une enquête transversale utilisant les données 2015-2016 collectées par le Centre national des maladies transmissibles et le ministère de la Santé de Mongolie. La population étudiée comptait 3 787 cas confirmés de rougeole. Résultats. Sur 3 787 sujets, 62,6 % étaient âgés de moins de 6 ans, 50,6 % étaient des hommes, 80,4 % des sujets venaient d'Oulan-Bator (la capitale de la Mongolie) et 69,3 % étaient au chômage. En termes de caractéristiques cliniques, presque tous les sujets (98 % et plus) ont présenté de la fièvre et des éruptions cutanées ; 62,5 % avaient de la toux et environ un quart avaient un coryza et des yeux rouges. Sujets originaires d'autres villes ou zones rurales (OR=1,32, IC 95 % : 1,12-1,57), chômeurs (OR=1,44, IC 95 % : 1,14-181) qui avaient de la fièvre OR=2,22 ; IC à 95 % : 1,25-3,95) avait une éruption cutanée (OR=2,16 ; IC à 95 % 1,14-4,89), avait de la toux (OR=1,63 ; IC à 95 % : 1,42-1,87), avait un coryza (OR=4,46 ; IC à 95 % : 3,79-5,26), avaient les yeux rouges (OR=2,2195 %, IC : 1,91-2,56) et avec une PCR positive pour la rougeole (OR=2,28, 95 % IC : 1,98-2,61) étaient plus susceptibles d'avoir un résultat de santé négatif par rapport aux groupes de référence.. Conclusion. Une prévalence plus élevée de la rougeole a été observée chez les enfants âgés de moins de 6 ans et les adultes âgés de 18 ans et plus. Le risque de rougeole était plus élevé parmi les cas présentant des symptômes cliniques. Davantage de programmes d’intervention, notamment la vaccination des enfants et des adultes, devraient être mis en œuvre pour atténuer la rougeole et réduire la transmission.

Keywords

Measles confirmed case mortality vaccination Mongolia Rougeole cas confirmé mortalité vaccination Mongolie

Article Details

How to Cite
Ghislain Gnimbar Poda, & Nyamtsatsral Batmunkh. (2023). Magnitude and Associated Factors with Measles Among General Population in Mongolia: Evidence from National Health Surveys 2015-2016. HEALTH SCIENCES AND DISEASE, 24(12). https://doi.org/10.5281/hsd.v24i12.5009

References

  1. World Health Organization. Media center. Measles: WHO; 2017a. Retrieved from http://www.who.int/mediacentre/factsheets/fs286/en / [cited 2017 March 14]
  2. World Health Organization. Global Measles and Rubella: Strategic Plan, 2012-2020. Geneva, WHO, 2012. Available on http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396_eng.pdf .
  3. Black FL. Measles. In: Viral infections in humans: Epidemiology and control, Evans AS, Kaslow RA (Eds), Plenum Publishing, New York 1997. p.507.
  4. Bellini WJ, Rota PA. Biological feasibility of measles eradication. Virus Res. 2011 Dec; 162(1-2):72-9.
  5. Keegan R, Dabbagh A, Strebel PM, Cochi SL. Comparing measles with previous eradication programs: enabling and constraining factors. J Infect Dis. 2011 Jul;204 Suppl 1:S54-61. doi: 10.1093/infdis/jir119.
  6. Patel MK, Gacic-Dobo M, Strebel PM, Dabbagh A, Mulders MN, Okwo-Bele JM, Dumolard L, Rota PA, Kretsinger K, Goodson JL. Progress Toward Regional Measles Elimination - Worldwide, 2000-2015. MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1228-1233. doi: 10.15585/mmwr.mm6544a6.
  7. World Health Organization, Western Pacific Region. Measles. Geneva , WHO, 2016. Available from http://iris.wpro.who.int/bitstream/handle/10665.1/13533/Measles-Rubella-Bulletin-2016-Vol-10-No-12.pdf?ua=1
  8. Teleb N, Lebo E, Ahmed H, Hossam AR, El Sayed el T, Dabbagh A, Strebel P, Rota P, Alexander J; Centers for Disease Control and Prevention (CDC). Progress toward measles elimination--Eastern Mediterranean Region, 2008-2012. MMWR Morb Mortal Wkly Rep. 2014 Jun 13;63(23):511-5.
  9. Mongolia Ministry of Health. Annual report, Ministry of Health: Ulaanbaatar, Mongolia, 2016
  10. Munkhjargal I, Selenge J, Ambaselmaa A, Tuul R, Delgermaa P, Amarzaya S, Baigalmaa J, Byambajav B, Luo D. Investigation of a mumps outbreak in Mongolia, January to April 2011. Western Pac Surveillance Response J. 2012 Dec 12;3(4):53-8. doi: 10.5365/WPSAR.2012.3.3.007. Print 2012 Oct.
  11. Rentsen T, Enkhtuya B, Nymadawa P, Kobune F, Suzuki K, Yoshida H, Hachiya M. Measles outbreak after a post-honeymoon period in Mongolia, 2001. Jpn J Infect Dis. 2007 Jul; 60(4):198-9.
  12. Featherstone D, Brown D, Sanders R. Development of the global measles laboratory network. J Infect Dis 2003; 187: S264-9 doi: 10.1086/368054 pmid: 12721924.
  13. Zahoor MA, Rasool MH, Waseem M, Aslam B, Zahoor MK, Saqalein M, Nawaz Z1, Sahar R1. Prevalence of measles in vaccinated and non-vaccinated children. EXCLI J. 2015 Apr 1;14:504-7.
  14. Mandomando I, Naniche D, Pasetti MF, Cuberos L, Sanz S, Vallès X, Sigauque B, Macete E, Nhalungo D, Kotloff KL, Levine MM, Alonso PL. Assessment of the epidemiology and burden of measles in Southern Mozambique. Am J Trop Med Hyg. 2011 Jul;85(1):146-51.
  15. Ma C, Yan S, Su Q, Hao L, Tang S1, An Z1, He Y1, Fan G1, Rodewald L1, Wang H2. Measles transmission among adults with spread to children during an outbreak: Implications for measles elimination in China, 2014. Vaccine. 2016 Dec 12;34(51):6539-6544.
  16. Cardemil CV, Jonas A, Beukes A, Anderson R, Rota PA, Bankamp B, Gary HE Jr2, Sawadogo S3, Patel SV3, Zeko S2, Muroua C2, Gaeb E5, Wannemuehler K6, Gerber S3, Goodson JL6. Measles immunity among pregnant women aged 15-44 years in Namibia, 2008 and 2010. Int J Infect Dis. 2016 Aug; 49:189-95.
  17. Gonwong S, Chuenchitra T2, Khantapura P3, Islam D3, Mason CJ3. Measles susceptibility in young Thai men suggests need for young adult measles vaccination: a cross sectional study. BMC Public Health. 2016 Apr 11; 16:309. doi: 10.1186/s12889-016-2987-z.
  18. Fitzpatrick G, Ward M, Ennis O, Johnson H, Cotter S, Carr MJ, O Riordan B, Waters A, Hassan J, Connell J, Hall W, Clarke A, Murphy H, Fitzgerald M. Use of a geographic information system to map cases of measles in real-time during an outbreak in Dublin, Ireland, 2011. Euro Surveill. 2012 Dec 6;17(49). pii: 20330.
  19. World Health Organization: Children's environmental health. Geneva, 2017b. Available from http://www.who.int/ceh/risks/en/
  20. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004 May 1;189 Suppl 1:S4-16.
  21. Zipprich J, Zahn M2, Harriman K1, Cherry JD3. Clinical Characteristics and Factors Associated With Measles Transmission in California. Open Forum Infect Dis. 2015 Dec 9;2(Suppl 1). pii: LB-4.
  22. Mahamud A1, Burton A, Hassan M, Ahmed JA, Wagacha JB, Spiegel P, Haskew C, Eidex RB, Shetty S, Cookson S, Navarro-Colorado C, Goodson JL. Risk factors for measles mortality among hospitalized Somali refugees displaced by famine, Kenya, 2011. Clin Infect Dis. 2013 Oct;57(8):e160-6. doi: 10.1093/cid/cit442. Epub 2013 Jul 2.
  23. Akramuzzaman SM, Cutts FT, Hossain MJ, Wahedi OK, Nahar N, Islam D, Shaha NC, Mahalanabis D. Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh. Bull World Health Organ. 2002;80(10):776-82.